FDA finalizes ‘mad cow disease’ rules

On Thursday, the U.S. Food and Drug Administration today issued a rule finalizing three previously-issued interim final rules designed to further reduce the potential risk of bovine spongiform encephalopathy (BSE), sometimes referred to as "mad cow disease," in human food. The final rule provides definitions for prohibited cattle materials and prohibits their use in human ["]